Nicotinell Spearmint (Nicotine Polacrilex)

Nicotinell Spearmint, a nicotine replacement therapy, is employed within the smoking cessation pathway to manage nicotine dependence.

• Smoking cessation: helps reduce withdrawal symptoms and cravings, supporting a gradual reduction in cigarette use.
• Tobacco dependence: provides controlled nicotine delivery to replace smoking and facilitate behavior change.
• Relapse prevention: maintains low nicotine levels to diminish the risk of returning to regular smoking after initial quitting.

• Nicotine Polacrilex is a nicotine salt complex that releases nicotine in the oral cavity, where it binds to nicotinic acetylcholine receptors on the mucosal epithelium. This agonist activity stimulates the same neuronal pathways activated by tobacco smoke, delivering a steady plasma nicotine concentration that alleviates withdrawal while avoiding the harmful combustion products of cigarettes. The gradual release reduces peaks and troughs, providing a more tolerable pharmacokinetic profile compared with smoking.

Nicotinell Spearmint may cause a range of oral and systemic reactions, which are classified by frequency and severity.

Common Side Effects

• Mouth irritation: mild soreness or tingling in the oral cavity.
• Throat irritation: discomfort or scratchy feeling in the throat.
• Hiccups: brief involuntary diaphragmatic contractions.
• Nausea: mild upset stomach or feeling of queasiness.
• Dyspepsia: indigestion or abdominal discomfort.
• Headache: transient mild to moderate head pain.

Serious or Rare Side Effects

• Allergic reaction: rash, swelling, or difficulty breathing indicating hypersensitivity.
• Oral ulceration: painful sores developing on the mucosa.
• Increased blood pressure: notable rise in systolic or diastolic readings.
• Arrhythmia: irregular heart rhythm requiring medical attention.
• Severe nausea or vomiting: persistent and intense gastrointestinal distress.
• Respiratory depression: reduced breathing effort, a medical emergency.

Before using Nicotinell Spearmint, consider the following precautions to ensure safe and effective use.

• Cardiovascular assessment: evaluate patients with heart disease or recent myocardial infarction before initiating therapy.
• Pregnancy and lactation: avoid use unless the benefits outweigh potential risks, and consult a healthcare professional.
• Age restriction: not recommended for children or adolescents under 18 years of age.
• Concomitant nicotine products: do not combine with other nicotine replacement therapies to prevent excess nicotine exposure.
• Known hypersensitivity: discontinue if signs of allergic reaction appear.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotinell Spearmint can interact with other substances; awareness of major and moderate interactions helps manage safety.

Major Interactions (Avoid)

• Other nicotine replacement products: concurrent use can lead to nicotine overdose.
• Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive reactions when combined with nicotine.

Moderate Interactions (Monitor Closely)

• Antihypertensive medications: nicotine may counteract blood pressure‑lowering effects.
• Caffeine: nicotine can enhance caffeine metabolism, potentially increasing stimulant effects.
• Bupropion: combined use may raise seizure risk, requiring careful monitoring.
• Alcohol: may intensify nicotine cravings and affect tolerability.